CSIMarket Company Name, Ticker, Competitors, else..
 
Immix Biopharma Inc   (NASDAQ: IMMX)
 

Immix Biopharma Inc's Suppliers Performance

IMMX's Supply Chain



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

 
IMMX Costs vs Sales of Suppliers Growth

• More on IMMX Suppliers






Immix Biopharma Inc's Comment on Supply Chain


The company develops its supply chain for product candidates through agreements with third-party contract manufacturers (CMOs) to supply active pharmaceutical ingredients (API) and drug products on a project-by-project basis. It relies on these CMOs for pre-clinical, clinical, and potential commercial manufacturing. Additional third parties are contracted for filling, labeling, packaging, storage, and distribution of investigational drug products. This strategy enables the company to focus on product development without investing in its own manufacturing facilities. Agreements with manufacturers include provisions for confidentiality, intellectual property, and quality to protect proprietary rights and comply with regulatory requirements.

Immix Biopharma Inc's Comment on Supply Chain


The company develops its supply chain for product candidates through agreements with third-party contract manufacturers (CMOs) to supply active pharmaceutical ingredients (API) and drug products on a project-by-project basis. It relies on these CMOs for pre-clinical, clinical, and potential commercial manufacturing. Additional third parties are contracted for filling, labeling, packaging, storage, and distribution of investigational drug products. This strategy enables the company to focus on product development without investing in its own manufacturing facilities. Agreements with manufacturers include provisions for confidentiality, intellectual property, and quality to protect proprietary rights and comply with regulatory requirements.







IMMX's vs. Suppliers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)



COMPANY NAME MARKET CAP REVENUES INCOME EMPLOYEES
Immix Biopharma Inc 818.19 0.00 -39.92 21
SUBTOTAL 0.00 0.00 0.00 -


Sources: Immix Biopharma Inc 's official press releases and regulatory filings; CSIMarket.com's supply-chain research; and the financial filings and press releases of other companies cited in this report.
Updated on:
For your research, we’ve provided nine additional tables on Immix Biopharma Inc ’s suppliers.
You can find them in the navigation menu under Suppliers.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.